Regulation of Human Immunodeficiency Virus Infection: Implications For Pathogenesis
Advances in Virus Research, ISSN: 0065-3527, Vol: 43, Issue: C, Page: 53-145
1994
- 52Citations
- 14Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations52
- Citation Indexes52
- 52
- CrossRef41
- Captures14
- Readers14
- 14
Article Description
Despite the intensive investigation, much remains to be learned about the sequence of events leading to the development of the acquired immunodeficiency virus syndrome (AIDS) following human immunodeficiency virus (HIV) infection. The development of AIDS is the culmination of a progressive infection with HIV, whose course and outcome are determined by the interactions between viral and host cellular factors, possibly influenced by additional agents or “cofactors”. One important factor in disease progression is the extent of viral replication at various times of postinfection. While the nature and effectiveness of the host immune response clearly play important roles in determining the amount of HIV replication, intrinsic viral factors also contribute. The cytopathicity and tropism of HIV isolates vary during the course of disease and may be important in the progression of AIDS. Furthermore, the amount of virus replication is a direct result of the molecular regulatory pathways governing the HIV gene expression. Efficient HIV gene expression results in abundant production of progeny viral particles, with the potential for increased infection of CD4+ T lymphocytes. Conversely, low-level HIV production may lead to the establishment of “latent” reservoirs of HIV, resulting in persistence or chronicity of infection. This chapter focuses on the aspects of HIV molecular biology and gene expression that influence the degree of viral production. The molecular mechanisms, by which the host cellular factors and heterologous infectious agents augment (or in some cases inhibit), HIV gene expression are discussed and the potential role that these various regulatory influences play in the progression of HIV infection is considered in this chapter. This chapter focuses on the regulation of HIV-1, the predominant cause of HIV disease in the world; HIV-2, a much rarer cause of AIDS, shares many of the same regulatory pathways of HIV-1.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0065352708600470; http://dx.doi.org/10.1016/s0065-3527(08)60047-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0028002972&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/8191958; http://linkinghub.elsevier.com/retrieve/pii/S0065352708600470; https://linkinghub.elsevier.com/retrieve/pii/S0065352708600470; http://dx.doi.org/10.1016/s0065-3527%2808%2960047-0; https://dx.doi.org/10.1016/s0065-3527%2808%2960047-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know